ovarian carcinoma in relapse
Conditions
Interventions
Trade Name: Eloxatin
Product Name: Eloxatin
Product Code: L01XAO3
Pharmaceutical Form: Concentrate for solution for infusion
INN or Proposed INN: Eloxatin
Current Sponsor code: oxaliplatin 1
Other des
Sponsors
Institut Jules Bordet
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Ovarian cancer recurrent disease first and later platinum-sensitive relapse second and later platinum-sensitive relapse Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: previous whole abdominal radiotherapy pregnancy unstable angina or myocardial infarction in the last six months severe hypersensitivity to platin compounds
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: to assess objective response rate ;Secondary Objective: to assess time to progression, overall survival ;Primary end point(s): objective response rate | — |
Countries
Belgium
Outcome results
None listed